Cost of Management of CKD3-5ND in an Out-of-Pocket Expenditure System
978-3-330-32719-1
3330327197
64
2017-06-05
35.90 €
eng
https://images.our-assets.com/cover/230x230/9783330327191.jpg
https://images.our-assets.com/fullcover/230x230/9783330327191.jpg
https://images.our-assets.com/cover/2000x/9783330327191.jpg
https://images.our-assets.com/fullcover/2000x/9783330327191.jpg
Chronic kidney disease affects about 10 % of the world population. In most developing nations, the costs for the treatment of CKD are met by patients. Data on the economic burden of early stages of CKD are scarce; few studies have evaluated the cost of management of CKD stages 3-5 non-dialyzed in an out-of-pocket expenditure system. This study estimated the direct, indirect and the global economic cost of management of CKD stages 3-5 ND patients in Yaoundé. It was a month retrospective cost analysis. Sampling was consecutive and exhaustive of CKD 3-5 ND patients. We evaluated direct medical, direct non-medical and indirect costs. 69 patients were included in the study and the mean age was 55 years. The median monthly salary of the population was $ 162. Only 1.4% of patients had 100% coverage. The total cost of management was about $ 163. Direct medical, direct non-medical and indirect costs accounted for 86.4 %, 7.1 % and 6.3 % respectively. That global cost was prohibitive to Cameroonians and was tantamount to 2.7 times the minimal wage in Cameroon. There is an urgent need for establishing a national health insurance Scheme in these countries.
https://morebooks.de/books/tr/published_by/lap-lambert-academic-publishing/47/products
https://morebooks.de/store/tr/book/cost-of-management-of-ckd3-5nd-in-an-out-of-pocket-expenditure-system/isbn/978-3-330-32719-1